Grants and Contracts Details
Whereas, CHMC and UKRF desire to enter into an agreement with the goal of increasing access to Patients to novel pediatric cancer research therapies under the aegis of CHMC, specifically in the ares of anti-cancer treatment and bone marrow transplant regimens.
|Effective start/end date||9/1/14 → 10/31/18|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.